Richter On Formycon Investment: ‘Indispensable’ To Partner On Everything We Do
As Hungarian Firm Offers ‘Commitment’ For Biotechnology Business To Break Even
Fledgling biosimilars player Gedeon Richter has spoken candidly and openly with investors on its recent biosimilar investments, its goal to start generate cash from its young Biotech business, and its need to manage costs in order to make that happen.
